Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-Label, Phase 2 Study of NGX-4010 for the Treatment of Neuropathic Pain in Patients With Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)
Conditions
Interventions
Capsaicin Dermal Patch
Start Date
August 1, 2005
Completion Date
December 1, 2006
Last Updated
March 6, 2008
NCT06346132
NCT07482709
NCT07351968
NCT06946290
NCT07041736
NCT06528288
Lead Sponsor
NeurogesX
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions